ScienTek

Startup

ScienTek is pioneering a transformative approach to diagnostics with its end-to-end aptamer discovery and validation platform that seamlessly integrates AI, molecular modeling and biotechnology. Our proprietary system accelerates the development of next-generation aptamer-based binding molecules. At the heart of our innovation is an AI-driven computational engine that uses extensive biological databases, predictive and molecular modeling to virtually screen trillions of aptamer-target interactions. This enables rapid identification of high-aBinity candidates with optimal structural and functional properties. Our extensive aptamer library targets both small molecules and proteins and oBers broad utility for all diagnostic applications. What sets ScienTek apart is our in-house wet lab facility where the best computational hits are subjected to high throughput fluorescence assays and rigorous in vitro testing to confirm their potency and specificity. This tightly integrated cycle between in silico prediction and experimental validation dramatically shortens development times; turning concepts into validated candidates in months rather than years. By combining computational power and experimental precision, ScienTek is not only accelerating the pace of diagnostic innovation, but also redefining how precision diagnostics are discovered and developed. We are setting the standard for the future of molecular diagnostics